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Accumulation of misfolded proteins in the endoplasmic reticulum (ER) and their 
aggregation impair normal cellular function and can be toxic, leading to cell death. 
Prolonged expression of misfolded proteins triggers ER stress, which initiates a 
cascade of reactions called the unfolded protein response (UPR). Protein misfolding 
is the basis for a variety of disorders known as ER storage or conformational diseases. 
There are an increasing number of eye disorders associated with misfolded proteins 
and pathologic ER responses, including retinitis pigmentosa (RP). Herein we review 
the basic cellular and molecular biology of UPR with focus on pathways that could 
be potential targets for treating retinal degenerative diseases.
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EnDoPlASMiC RETiCUlUM STRESS AnD 
PRoTEin folDing 
The endoplasmic reticulum (ER) is the principal 
site for synthesis and maturation of secretory 
and transmembrane proteins. More than 
30% of cellular proteins are synthesized in 
the ER.1 Folding is the most critical step in 
protein synthesis. Any delay in or impairment 
of protein folding and processing results in 
accumulation of misfolded protein triggering ER 
stress which is a response characterized by ER 
distension and perturbation in ER homeostasis.2 
Accumulation of misfolded proteins and/
or their aggregation are toxic to the cell and 
impair normal cellular function. To cope with 
any perturbation by unfolded or misfolded 
proteins, the ER induces a cascade of reactions 
called the unfolded protein response (UPR).3 ER 
stress is the precursor of UPR, however these 
terms have been used interchangeably and 
will be used as such throughout this review. 
Protein misfolding is the basis for a 
variety of disorders known as ER storage or 
conformational diseases.4,5 However, recent 
studies show that UPR is activated during normal 
cellular events such as B-cell differentiation,6 
muscle differentiation,7 or viral infections.8,9 The 
common theme in these events which trigger 
the UPR response is the build-up of unfolded 
proteins.10-15
Generally, cellular responses in UPR are 
composed of (1) translational attenuation 
to prevent further production of unfolded Endoplasmic Reticulum Stress; Haeri and Knox
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proteins,16 (2) transcriptional induction of ER 
resident proteins (chaperones and foldases) to 
further assist protein folding,17 (3) induction of 
ER-associated degradation (ERAD) machinery 
to handle misfolded proteins and reduce 
the burden on ER folding capacity,18 and (4) 
enlargement of the ER to deal with the large load 
of unfolded proteins.19 The successful execution 
of compensatory responses to stress by these 
mechanisms restores normal cell function and 
survival. Alternatively, irreversibly stressed 
cells will undergo apoptosis in response to 
prolonged UPR (Fig. 1).
The ER stress response is mediated by 
three receptors located in the ER membrane. 
Translational attenuation in the UPR is mediated 
by the double-stranded RNA-activated protein 
kinase (PKR)-like endoplasmic reticulum kinase 
(PERK) signalling pathway. PERK receptors sense 
the presence of unfolded proteins20 and reduce 
the activity of the ribosomal initiating factor 
(eIF2α) by phosphorylation of its α-subunit.16 
Transcriptional activation of ER-resident 
proteins is mediated by activating transcription 
factor 6 (ATF6)21 and inositol requiring kinase 1 
(IRE1) receptors. In a similar mechanism to PERK 
receptors, ATF6 and IRE1 receptors sense the 
accumulation of misfolded proteins and induce 
the transcription of ER-resident proteins to assist 
folding and to degrade misfolded proteins. 
ATF6 activates the transcription of molecular 
chaperones such as BiP, GRP9417 and PDI22. IRE1 
induces the synthesis of a potent X-box-binding 
protein 1 (XBP1) and consequently activates 
figure 1. Major unfolded protein response (UPR) pathways. The influx of unfolded proteins in the endoplasmic 
reticulum (ER) induces UPR. UPR is relayed to the cell by activation of three receptors: IRE1, PERK and ATF6. Induction 
of these pathways starts processes to (1) decrease the load of protein by translational attenuation, (2) to increase the 
folding capacity of the ER, and (3) to decrease the protein load in the ER by degradation of unfolded proteins. Cells 
which fail to restore their normal cellular function experience prolonged activation of UPR resulting in apoptosis.Endoplasmic Reticulum Stress; Haeri and Knox
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the transcription of ER associated degradation 
(ERAD) proteins such as EDEM.23,24 IRE1 also 
activates the transcription of other UPR target 
genes, such as BiP, through XBP1 activation25 
(Fig. 2). 
To assist protein folding in the UPR, BiP 
is the first target for upregulation. BiP is a 
molecular chaperone with high affinity for 
short hydrophobic peptides on the surface of 
unfolded proteins. The binding and releasing 
of these peptides from BiP assist the folding 
of the substrate protein.26,27 BiP is also a sensor 
for unfolded proteins in the ER. An overload of 
unfolded proteins in the ER titrates BiP away 
from the luminal domains of IRE1, PERK and 
ATF6 receptors, which results in their further 
homodimerization, autophosphorylation and 
activation16,20,28. The dissociation of BiP from 
the ATF6 luminal domain leaves ATF6 free to 
be transported to the Golgi where it is cleaved 
to become an active transcription factor29 (Fig. 
2). Downstream UPR target genes are regulated 
by two distinct consensus response elements, the 
cis-acting ER stress response element (ERSE) and 
the unfolded protein response element (UPRE) 
both of which are located in the promoter of 
genes involved in UPR. Binding of ATF621 and 
XBP1 to these elements promotes transcription 
of downstream UPR genes30,31.
The IRE1, PERK and ATF6 receptors initiate 
pathways, which comprise the three arms of 
the UPR. Located in the ER membrane, these 
receptors have a transmembrane domain 
spanning the ER membrane, a cytosolic or 
nucleoplasmic domain, and a luminal domain 
that has a binding site for BiP. IRE1 receptor is 
a type I transmembrane protein kinase receptor 
which has site-specific endoribonuclease (RNase) 
activity in its cytosolic domain.32-35 IRE1 is highly 
conserved in eukaryotes.28,32,33,36-38 Two types of 
IRE1 receptors have been found in mammals. 
IRE1α is ubiquitously expressed in all tissues, 
but the expression of the second type, IRE1β, 
is limited to the gut.20,34,35,39 Deletion of IRE1α 
is lethal in mice; however, IRE1β−/− mice are 
viable.20,39 The luminal domain of the IRE1 
receptor binds to BiP. Accumulation of unfolded 
proteins in the ER, results in BiP release from 
the IRE1 luminal domain which in return causes 
dimerization and autophosphorylation of IRE1. 
Phosphorylation of the cytosolic domain of the 
IRE1 receptor activates its RNase activity.30,31,40-42 
In mammals, XBP1 mRNA is the substrate for 
IRE1 endoribonuclease.30,31,40 XBP1, a bZIP 
(basic region and leucine zipper)-domain-
containing transcription factor of the ATF/
CREB (cyclic-AMP-responsive-element-binding 
protein) family, binds to ERSE.21,43 During ER 
stress, IRE1 endoribonuclease splices out a 
26-nucleotide intron from XBP1 mRNA and 
creates a translational frameshift. This spliced 
form of XBP1 becomes an active transcription 
factor.15,30,31,40 XBP1 then translocates to the 
nucleus and induces the transcription of genes 
involved in protein folding and degradation 24,40 
44-48 (Fig. 2).
The PERK receptor is a type I 
transmembrane protein kinase receptor which 
is activated by ER stress with the release of 
BiP from its luminal domain. Release of BiP 
from PERK, results in its oligomerization 
with subsequent autophosphorylation of its 
cytosolic domain.16,20,21,49 Activated PERK 
receptors phosphorylate the α-subunit (S51) 
of eIF2 (eIF2α), which inhibits 80S ribosome 
assembly and consequently attenuates protein 
synthesis/translation.16,50,51 The inhibition of 
ribosomal assembly reduces the influx of newly 
synthesized proteins to an already saturated ER. 
In contrast, phosphorylation of eIF2α promotes 
the translation of ATF4 upon ER stress.11,52,53 
ATF4 is a transcription factor which activates the 
transcription of chaperones, ERAD machinery 
and other genes involved in the oxidative stress 
response and ER stress-induced apoptosis20,54-56, 
such as C/EBP homologous transcription factor 
(CHOP), growth arrest and DNA damage gene 
34 (GADD34)20,57-59 and ATF358. 
The ATF6 receptor is a type II transmembrane 
protein with a cytosolic/nucleoplasmic and an 
ER luminal domain.60 Mammals have two ATF6 
homologs, ATF6α and ATF6β.61 There are two 
distinct ER stress-regulated Golgi localization 
sequences (GLS1 and GLS2) in the luminal 
domain of ATF6α and one GLS2 in that of ATF6β. 
BiP binds to GLS1 and retains the ATF6 receptor 
within the ER. Release of BiP from GLS1 upon 
ER stress results in ATF6 translocation to the Endoplasmic Reticulum Stress; Haeri and Knox
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figure 2. Unfolded protein response (UPR). The ER stress response is mediated by three receptors located in the ER 
membrane. The IRE1 pathway is activated by the release of BiP from IRE1 which is followed by dimerization and 
autophosphorylation of its cytoplasmic domain. The activated IRE1 receptor triggers its intrinsic RNase activity, which 
splices out a 26-nucleotide intron from XBP1 mRNA and creates a translational frameshift leading to production of 
an active transcription factor, XBP1. XBP1 activates the transcription of ERAD-related proteins (red-dotted area). 
Chronic activation of IRE1 leads to recruitment of TRAF2 followed by activation of ASK1, p38 and JNK. Activated 
JNK translocates to the mitochondrial membrane and promotes phosphorylation of Bim, which is associated with 
Bax-dependent release of cytochrome c and activation of the caspase cascade. The PERK pathway is activated by 
the release of BiP generating a dimerized-phosphorylated PERK enzyme which reduces the activity of the eIF2α by 
phosphorylation of its α-subunit. Although the phosphorylation of eIF2α generally attenuates protein synthesis/
translation, it promotes the translation of ATF4 upon ER stress. ATF4 activates the transcription of chaperones, ERAD 
machinery and ER-stress-induced pro-apoptotic factors, such as CHOP and GADD34 and ATF3 (green-dotted area). 
In the ATF6 pathway, the release of BiP from the ATF6 receptor frees the receptor to be transported to the Golgi. 
Once in the Golgi, the cytosolic domain is cleaved by S1P and S2P, releasing a bZIP transcription factor, ATF6. ATF6 
translocates to the nucleus where it activates the transcription of BiP, XBP1, CHOP and P58IPK (blue-dotted area).Endoplasmic Reticulum Stress; Haeri and Knox
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Golgi.62 The cytosolic domain of ATF6 in the 
Golgi is cleaved by site-1 proteases (S1P and S2P) 
releasing a bZIP transcription factor, ATF6.18,29,63-
65 ATF6 translocates to the nucleus where it 
interacts with nuclear factor-Y and XBP1, binds 
to ERSE and UPRE elements and activates the 
transcription of BiP, XBP1, CHOP and P58IPK 
18,21,66-69 (Fig. 2). Activated ATF6 also induces the 
expression of genes involved in protein folding 
and degradation.63, 64 
PRo-APoPToTiC PATHwAyS in 
EnDoPlASMiC RETiCUlUM STRESS
Prolonged ER stress seems to activate IRE1α, 
ATF6 and PERK pathways sequentially and 
deactivates them in the same order.70 If the UPR 
response fails to restore cellular homeostasis, the 
cell initiates apoptosis.53,71,72 Prolonged ER stress-
induced apoptosis is an important pathologic 
element of neurodegenerative diseases, 
diabetes, renal diseases and atherosclerosis.73 
Generally, apoptosis is known as the nuclear 
form of programmed cell death (PCD). Other 
types of PCDs are autophagic (type II)74-76 
and cytoplasmic (type III) PCD75-78. The PCD 
associated with UPR is probably the nuclear 
form. Four known pro-apoptotic pathways 
have been implicated in ER-stress mediated 
apoptosis; 1) IRE1α-mediated activation of 
ASK1 (apoptosis signal-regulating kinase 1), 
2) caspase-1279, 3) PERK/eIF2α induction of 
CHOP, and 4) BAK/BAX-induced Ca2+ release 
from the ER 35,80.
Apoptosis signalling is mediated by two 
major pathways. The extrinsic pathway is 
triggered by self-association of membrane 
receptors and recruitment of caspase-9 which 
results in initiation of a caspase cascade and 
finally apoptosis. The intrinsic pathway is 
triggered by dominance of pro-apoptotic over 
anti-apoptotic members of the Bcl-2 family. 
Anti-apoptotic members of the Bcl-2 family are 
Bcl-2 and Bcl-XL, and pro-apoptotic members 
are BH3-only classes including Bid and Bim as 
well as multidomain groups, such as Bax and 
Bak. A variety of apoptotic stimuli promote 
translocation of Bax and Bak from the cytosol 
into the mitochondria resulting in release of 
cytochrome c and activation of caspases.81
The IRE1/TRAF2/ASK1/JNK pathway is 
considered the dominant pro-apoptotic pathway 
in ER stress. It has been shown that IRE1α is able to 
recruit TNF receptor-associated factor 2 (TRAF2) 
to its cytosolic domain. TRAF2 can subsequently 
activate apoptosis signal-regulating kinase 
(ASK) 1, p38 and finally c-Jun amino-terminal 
kinase (JNK).20,28,82 Co-expression of ASK1 and 
JNK results in phosphorylation and inactivation 
of Bcl-2.83 Activated JNK has been shown to 
translocate to the mitochondrial membrane84 
and promote phosphorylation of Bim, which 
is associated with Bax-dependent release of 
cytochrome c85,86. ASK1 can also be activated 
by reactive oxygen species (ROS) initiating 
apoptosis. ASK1 is inhibited by thioredoxin 
(TDX), a protein which inactivates ROS, until 
accumulation of ROS causes oxidation of TDX, 
thereby disinhibition of ASK1.28,87 IRE1α can also 
induce apoptosis through 1) interaction of the 
TNF receptor 1 (TNFR1) with TRAF2/ASK1 and 
subsequent activation of JNK and through 2) 
interaction of TRAF2 and the inhibitor of κB-
kinase (IKK) which leads to activation of nuclear 
factor κB88,89.
The PERK/ATF4/CHOP pathway is the 
second pro-apoptotic mechanism triggered by 
prolonged ER stress35,90,91. CHOP is minimally 
expressed under non-stress conditions; however, 
its expression is moderately increased upon ER 
stress. CHOP expression has been shown to 
induce cell cycle arrest and/or apoptosis.35,80,90-94 
Transcriptional activation of CHOP is mediated 
by the IRE1, PERK or ATF618,20,35,80,95 pathways. 
CHOP is also activated post-translationally via 
p38 MAP kinase phosphorylation.90 It has been 
shown that CHOP expression sensitizes the 
cell to apoptosis by downregulation of BCL-
2 and/or depletion of glutathione leading to 
accumulation of ROS in the cell93 (Fig. 2). CHOP 
expression promotes pro-apoptotic factors 
such as DR5, TRB3, BIM and GADD34 96-99. 
Association of CHOP with ER stress-induced 
apoptosis has been reported in diabetes,80,99 
renal dysfunction,35 atherosclerosis,100 cardiac 
overload,101 colitis,102 and Parkinson’s disease103. 
CHOP is a major pro-apoptotic factor in ER stress 
and its deletion promotes cell survival. Several Endoplasmic Reticulum Stress; Haeri and Knox
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therapeutic approaches have targeted the PERK-
CHOP pathway in a mouse model of ER stress to 
inhibit apoptosis. Blocking the phosphorylation 
of eIF2α by Salubrinal promoted cell survival 
in these mouse models implicated with   
ER stress.104
The PERK pathway is also induced by 
accumulation of ROS105,106. ROS are small 
molecules or free radicals (atoms, molecules 
or ions with unpaired electrons or open 
shelf configuration) formed by molecular 
oxygen.107 ROS have been linked to mediators 
of inflammation.108 Protein folding is an energy 
consuming process through which the formation 
of disulfide bonds is required for correct folding 
of some proteins.105, 106 To deal with ROS 
formed during protein folding in ER stress, 
the PERK pathway induces the transcription 
of glutathione S-transferase, NAD(P)H:quinone 
oxidoreductase-1, γ-glutamate cysteine ligase, 
and hemeoxygenase-1 to protect the cell from 
oxidative stress.44,54,109-124 Oxidative stress is 
believed to play an important role in age-
related macular degeneration (AMD), retinitis 
pigmentosa (RP) and other ocular diseases.125
Some evidence suggests a role for caspase-12 
as another pro-apoptotic pathway in ER stress.126 
Caspase-12 is a member of the group I family of 
caspases (also known as ICE-like caspases and 
consists of caspase-1, 4, 5, 11, and 13). Caspase-12 
is localized on the cytoplasmic side of the ER 
membrane127 and is associated with ER stress-
mediated apoptosis79. It has been shown that 
activated caspase-12 translocates to the cytosol 
and subsequently activates caspase-9 and 
caspase-3.128 Caspase-12 activation by amyloid 
β (Aβ) peptide through calpain has been shown 
in primary neurons.79 In humans, the functional 
caspase-12 homologue is not expressed due to a 
mutation129; therefore, other caspases may play 
a role in apoptosis.130 
nEURoDEgEnERATivE DiSEASES AnD UPR
Retinal degeneration is one of the leading causes 
of blindness in humans. The current hypothesis 
proposed for retinal degeneration elicited by ER 
stress is the activation of UPR pathways. Some 
types of retinal degenerations share similar 
pathological origins to neurodegenerative 
diseases. These include protein misfolding, 
aggregate formation and activation of 
protein degradation machinery. Furthermore, 
involvement of UPR has been suggested by cell 
culture studies and animal models.11,131 There 
are a few similarities found in the origins of 
neurodegenerative diseases and those found in 
retinal degenerations. A better understanding of 
the pathogenesis of neurodegenerative diseases 
could shed light on the molecular pathology of 
eye diseases. Neurodegenerative diseases are 
chronic conditions originating from mutations 
in genes that lead to neural cell death. In many 
neurodegenerative diseases, such as Alzheimer’s 
disease (AD), amyotrophic lateral sclerosis 
(ALS), Parkinson’s disease (PD), multiple 
sclerosis (MS) and polyglutamine diseases 
(which result from expansion of a polyglutamine 
repeat), the major molecular pathology is the 
formation of protein aggregates.132 Aggregate 
formation can limit or inhibit the capacity of 
the cell for ER-associated protein degradation 
(ERAD) by proteasomes. Failure of the cell to 
degrade misfolded aggregates induces UPR 
and eventually neural cell death.133, 134
Alzheimer’s disease is among the well 
known neurodegenerative diseases in which 
the PERK-EIF2α pathway is activated.14,135-138 
Juvenile-onset Parkinson’s disease is another 
example of UPR-driven cell death in which 
mutations in Parkin, an E3 ubiquitin ligase 
causes ER stress.139,140 The expression of wild type 
Parkin is induced by ER stress to clear misfolded 
proteins through ERAD.141 The overexpression 
of wild type Parkin promotes survival in cells 
expressing mutant α-synuclein or those treated 
with ER stress-inducing agents.140-142 Evidence 
of ER stress has been reported in other forms 
of neurodegenerative diseases such as ALS 
134, Huntington’s disease143-147 and diseases 
associated with Prions such as transmissible 
spongiform encephalopathies of Creutzfeldt-
Jakob disease and Kuru148.
RolE of UPR in EyE DiSEASES
UPR is a response to ER stress and is 
implemented differently depending on cell Endoplasmic Reticulum Stress; Haeri and Knox
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type, nature of ER stress, its magnitude and 
duration.89, 149, 150 UPR can serve to protect the 
cell by re-establishing ER homeostasis or it can 
trigger apoptosis under severe or chronic ER 
stress.151,152 The presence of misfolded protein 
is the trigger for induction of UPR. A growing 
number of reports suggest that misfolded 
proteins play a role in the pathogenesis of 
several eye disorders.153 Several studies have 
demonstrated the association of misfolded 
protein and UPR in RP. UPR might also be 
involved in the conversion of dry AMD to the 
wet form through angiogenesis stimulated by 
the vascular endothelial growth factor (VEGF) 
released from retinal pigmented epithelium 
(RPE) cells.154 UPR has also been implicated 
in the early onset form of Fuchs endothelial 
corneal dystrophy (FECD) which is the leading 
indication for corneal transplantation.155 Among 
other diseases that might be linked to ER stress, 
investigators have reported the activation of 
UPR by cataract-associated αA-crystallin156 
and collagen IV157 mutations in animal models. 
Moreover, possible involvement of ER stress 
has been proposed in adult-onset primary 
open angle glaucoma (POAG).158 Mutations in 
carbonic anhydrase (CA) IV, a highly expressed 
enzyme in the choriocapillaris of the human eye, 
are associated with the RP17 form of autosomal 
dominant RP due to accumulation of unfolded 
proteins in the ER.159-161 Besides the retina, 
other neuronal cells are subject to induction 
of UPR as shown in several neurodegenerative 
diseases. ALS,162 Parkinson’s, Huntington’s 
and Alzheimer’s disease, and prion-related 
disorders are among degenerative diseases 
associated with UPR.163
The association of UPR and visual impairment 
has been well described in animal models of 
RP. Among the over 40 genes causing RP, the 
most common forms of autosomal dominant RP 
are due to mutations in rhodopsin. Mutations 
in rhodopsin cause the formation of misfolded 
proteins which induce ER stress. Enormous 
amounts of rhodopsin are made every day and 
the overload of photoreceptors with misfolded 
rhodopsin triggers UPR. The induction of UPR 
has been observed in several animal models of 
RP.70, 164-166
UPR in RETinAl DEgEnERATion: 
PoTEnTiAl THERAPEUTiC APPRoACHES 
Photoreceptors synthesize a large amount 
of protein every day indicating the critical 
role for ER function in these cells. Altered 
expression of some molecular chaperones, the 
major component of protein folding and quality 
control in the ER, was found in proteomics of 
a murine model of retinal degeneration.11,167-169 
Some mutations in rhodopsin, which result in 
the production of misfolded proteins, lead to 
retinitis pigmentosa (RP). These types of RPs 
have been classified as ER storage diseases.3 
The expression level of ATF6, phosphorylated 
eIF2α, and CHOP in a rat model of RP expressing 
rhodopsin-P23H mutation were higher as 
compared to control animals. Overexpression 
of BiP in the P23H rat model led to a decrease 
in CHOP levels and apoptosis, and an increase 
in the amplitude of the electroretinogram164 
which indicates that increased folding capacity 
in cells may inhibit apoptosis. The expression 
of ER stress markers, XBP1 and Hrd1, was 
increased in a fly model of RP expressing 
mutant Rh1, the equivalent of rhodopsin in 
vertebrates. It was demonstrated that reduced 
function of ERAD led to an increase in mutant 
Rh1 which suggest its role in degradation of 
mutant opsin. On the other hand, overexpression 
of the ERAD machinery reduced the levels of 
mutant Rh1 and markers of ER stress.165 These 
reports demonstrated induction of UPR in 
animal models of retinal degeneration. They 
also exhibited a reduction in apoptosis by 
overexpression of chaperones, such as BiP. 
Several therapeutical approaches to 
alleviate retinal degeneration targeted protein 
folding by using chemical chaperones.170-172 
Chemical chaperones are small molecules 
which assist protein folding by non-covalent 
interactions with partially folded or misfolded 
proteins.64,172-176 Protein synthesis is an energy 
consuming process which is assisted and 
monitored by several proteins mostly residing 
in the ER. Among assistant proteins, chaperones 
stabilize partially folded proteins and bind 
to exposed hydrophobic surfaces to direct a 
forming protein to its native state. Failure to Endoplasmic Reticulum Stress; Haeri and Knox
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adopt the native conformation will target the 
misfolded protein to ER-associated degradation 
machinery to prevent aggregate formation.170 
However, this folding assistance and quality 
control might become overwhelmed due to 
other cellular insults such as oxidative stress, 
hypoxia, altered calcium homeostasis or vastly 
expressed inherently misfolded protein. To cope 
with this stress, the ER initiates a compensatory 
cascade of responses, i.e. the UPR,177 which is 
initially a survival response that reduces the 
general translation of proteins to alleviate the 
burden of protein folding on the ER, upregulates 
chaperones to facilitate protein folding and 
induces ER-associated degradation machinery. 
Failure of adopted strategies to recover from 
stress leads to induction of apoptosis to eliminate 
injured cell.137,167,178 Several neurodegenerative 
diseases are associated with misfolded proteins 
and consequently ER stress.11,131,137, 178 
Recent studies have demonstrated facilitated 
protein folding by pharmacological chaperones 
in models of RP. Some forms of RP are associated 
with misfolding of mutant rhodopsin, aggregate 
formation and targeted degradation by the 
ubiquitin proteasome system. Investigators 
studying P23H, the most common mutation 
found in rhodopsin, reported that 11-cis-7-ring 
retinal can promote proper folding, glycosylation 
and localization of P23H to the cell surface.179-181 
Rescue of misfolded P23H was achieved in 
another study by cotransfection of P23H with 
Hsp70, β-synuclein, or γ-synuclein chaperones 
in P661W photoreceptor cells and resulted in the 
formation of fewer inclusion bodies.182
Compounds known as chemical 
chaperones183,184 such as tauroursodeoxy-cholic 
acid (TUDCA) and 4-phenyl butyric acid, have 
origins in traditional Chinese medicine and have 
been used in humans for a variety of diseases 
including RP. Although some beneficial effects 
have been demonstrated, the definitive effect 
of chemical chaperones to inhibit ER stress-
induced apoptosis has not been proven.185-187
Several investigators have shown the 
effectiveness of a high-throughput screen for 
chemical chaperones to find a potent protein 
aggregate inhibitor. Accordingly, yeast cells 
expressing Htt-103Q-EGFP (Huntington  gene 
with extended polyglutamine fused to EGFP) 
were generated and demonstrated poor growth 
and low expression of the fusion protein. 
These cells were then treated with a library 
consisting of 16,000 different compounds and 
screened for restoration of cell growth and 
expression of fusion protein (Htt-103Q-EGFP). 
After finding effective compounds from the 
library, investigators examined the effect of 
hit compounds in the mouse and Drosophila 
model of Huntington’s disease.11 Future studies 
need to uncover the extent to which the UPR 
is induced in retinal degenerative diseases. A 
better understanding of the role of timing in the 
induction of UPR elements is crucial to target 
pro-apoptotic factors. High-throughput studies 
will play a major role in finding mechanisms of 
retinal degeneration and potential therapeutic 
compounds.
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